Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2007-07-03
2007-07-03
Swartz, Rodney P (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S185100, C424S192100, C435S253100, C530S300000, C530S350000, C536S023400, C536S023700
Reexamination Certificate
active
11028898
ABSTRACT:
Compounds and methods for inducing protective immunity against tuberculosis are disclosed. The compounds provided include polypeptides that contain at least one immunogenic portion of one or moreM. tuberculosisproteins and DNA molecules encoding such polypeptides. Such compounds may be formulated into vaccines and/or pharmaceutical compositions for immunization againstM. tuberculosisinfection, or may be used for the diagnosis of tuberculosis.
REFERENCES:
patent: 3943119 (1976-03-01), Tsumita et al.
patent: 5108745 (1992-04-01), Horwitz
patent: 6338852 (2002-01-01), Reed et al.
patent: 6544522 (2003-04-01), Skeiky et al.
patent: 419355 (1991-03-01), None
patent: 2244539 (1975-05-01), None
patent: 2265402 (1975-11-01), None
patent: WO 88/05823 (1988-08-01), None
patent: WO 91/04272 (1991-04-01), None
patent: WO 91/14448 (1991-10-01), None
patent: WO 92/04049 (1992-03-01), None
patent: WOX 92/14823 (1992-09-01), None
patent: WOX 92/21758 (1992-12-01), None
patent: WOX 94/00492 (1994-01-01), None
patent: WOX 95/01440 (1995-01-01), None
patent: WOX 95/01441 (1995-01-01), None
patent: WOX 95/14713 (1995-06-01), None
patent: WOX 95/31216 (1995-11-01), None
patent: WOX 96/15241 (1996-05-01), None
patent: WOX 96/23885 (1996-08-01), None
patent: WOX 97/09428 (1997-03-01), None
patent: WOX 97/09429 (1997-03-01), None
Singh, I.G., et al, “In vitro characterization of T cells fromMycobacteriumw- vaccinated mice.”, Infection and Immunity, vol. 60, No. 1,pp. 257-263, Jan. 1992.
Cameron, R.M. et al, “identification and characterization of a putative serine protease expressed in vivo byMycobacterium aviumsubsp.paratuberculous.”, Microbiology, vol. 140, pp. 1977-1982, Aug. 1994.
Andersen, et al., “Structure and Mapping of Antigenic Domains of Protein Antigen b, a 38,000-Molecular-Weight Protein ofMycobacterium tuberculosis,” Infection and Immunity, 1989, pp. 2481-2488, vol. 37, No. 9.
Andersen, et al., “Identification of Immunodominant Antigens during Infection withMycobacterium tuberculosis,” Scand. J. Immunol., 1992, pp. 823-831, vol. 36.
Andersen, P., “Effective Vaccination of Mice againstMycobacterium tuberculosisInfection with a Soluble Mixture of Secreted Mycobacterial Proteins,”Infection and Immunity, 1994, pp. 2536-2544, vol. 62, No. 6.
Ausebel et al., “Isolation of Proteins for Microsequence Analysis,”Current Protocols in Molecular Biology, 1993, pp. 10.19.1-10.19.12, Wiley & Sons, New York.
Barnes, et al., “Immunoreactivity of a 10-kDa Antigen ofMycobacterium tuberculosis,” The Journal of Immunology, 1992, pp. 1835-1840, vol. 148, No. 6.
Boesen et al., “Human T-Cell Responses to Secreted Antigen Fractions ofMycobacterium tuberculosis,” Infection and Immunity, 1995, pp. 1491-1497, vol. 63(4).
Borremans et al., “Cloning, Sequencing Determination, and Expression of a 32-Kilodalton-Protein Gene ofMycobacterium tuberculosis,” Infection and Immunity, 1989, pp. 3123-3130, vol. 57(10).
Cameron, Rona M. et al.; “Identification and characterization of a putative serine protease expressed in vivo byMycobacterium aviumsubsp.Paratuberculosis”; Microbiology1994 vol. 140 No. 8, pp. 1977-1982.
Content et al., “The Genes Coding for the Antigen 85 Complexes ofMycobacterium tuberculosisandMycobacterium bovisBCG Are Members of a Gene Family: Cloning, Sequence Determination, and Genomic Orginization of the Gene Coding for Antigen 85-C ofM. tuberculosis,” Infection and Immunity, 1991, pp. 3205-3212, vol. 59.
Horowitz et al., “Protective immunity against tuberculosis induced by vaccination with major extracellular proteins ofMycobacterium tuberculosis,” Proc. Natl. Acad. Sci. USA, 1995, pp. 1530-1534, vol. 92.
Lowrie et al., “Towards a DNA vaccine against tuberculosis,”Vaccine, 1994, pp. 1537-1540, vol. 12(16).
Matsumoto et al., “Cloning and Sequencing of a Unique Antigen MPT70 fromMycobacterium tuberculosisH37Rv and Expression in BCG UsingE. coli-MycobacteriaShuttle Vector,”Scand. J. Immunol., 1995, pp. 281-287, vol. 41.
Nagai et al., “Isolation and Partial Characterization of Major Protein Antigens in the Culture Fluid ofMycobacterium tuberculosis,” Infection and Immunity, 1991, pp. 372-382, vol. 59(1).
Oettinger et al., “Cloning and B-Cell-Epitope Mapping of MPT64 fromMycobacterium tuberculosisH37Rv,”Infection and Immunity, 1994, pp. 2058-2064, vol. 62(5).
Pal et al., “Immunization with Extracellular Proteins ofMycobacterium tuberculosisInduces Cell-Mediated Immune Responses and Substantial Protective Immunity in a Guinea Pig Model of Pulmonary Tuberculosis,”Infection and Immunity, 1992, pp. 4781-4792, vol. 60(11).
Romain et al., “Isolation of a proline-rich mycobacterial protein elicting delayed-type hypersensitivity reactions only in guinea pigs immunized with living mycobacteria,”Proc.Natl. Acad. Sci. USA, 1993, pp. 5322-5326, vol. 90.
Romain et al., “Preparation of Tuberculin Antigen L,”Ann. Inst. Pasteur/Microbiol., 1985, pp. 235-248, vol. 136B.
Skeiky, Yasir A. et al.; “Cloning, Expression, and Immunological Evaluation of Two Putative Secreted Serine Protease Antigens ofMycobacterium tuberculosis”; Infection and Immunity1999 vol. 67 No. 8, pp. 3998-4007.
Wallis et al., “Identification of Antigens ofMycobacterium tuberculosisUsing Human Monoclonal Antibodies,”J. Clin. Invest., 1989, pp. 214-219, vol. 8.
Wiker et al., “The Antigen 85 Complex: a Major Secretion Product ofMycobacterium tuberculosis,” Microbiological Reviews, 1992, pp. 648-661, vol. 56(4).
Yamaguchi et al., “Cloning and Characterization of the Gene for Immunogenic Protein MPB64 ofMycobacterium bovisBCG,”Infection and Immunity, 1989, pp. 283-288, vol. 57(1).
Young et al., “Screening of a Recombinant Mycobacterial DNA Library with Polyclonal Antiserum and Molecular Weight Analysis of Expressed Antigens,”Infection and Immunity, 1987, pp. 1421-1425, vol. 55(6).
Campos-Neto Antonio
Dillon Davin C.
Hendrickson Ronald C.
Houghton Raymond
Lodes Michael J.
Corixa Corporation
Swartz Rodney P
Townsend and Townsend / and Crew LLP
LandOfFree
Compounds and methods for immunotherapy and diagnosis of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and methods for immunotherapy and diagnosis of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and methods for immunotherapy and diagnosis of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3821619